OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2014-07-31
- Target Recruit Count
- 37
- Registration Number
- NCT01646827
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Inc., Garden Grove, California, United States
🇺🇸CNRI - San Diego, San Diego, California, United States
🇺🇸Community Clinical Research, Inc., Austin, Texas, United States
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
- Conditions
- Interventions
- First Posted Date
- 2012-03-30
- Last Posted Date
- 2018-08-24
- Target Recruit Count
- 731
- Registration Number
- NCT01567527
Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2014-10-10
- Target Recruit Count
- 60
- Registration Number
- NCT01552772
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Garden Grove, California, United States
🇺🇸Compass Research, LLC, Orlando, Florida, United States
🇺🇸CNRI-San Diego, San Diego, California, United States
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
- Conditions
- Interventions
- First Posted Date
- 2012-01-12
- Last Posted Date
- 2015-03-04
- Target Recruit Count
- 30
- Registration Number
- NCT01509053
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
- Conditions
- Interventions
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2017-04-10
- Target Recruit Count
- 40
- Registration Number
- NCT01483183
- Locations
- 🇬🇧
Otsuka Investigational Site, Chertsey, Surrey, United Kingdom
8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Conditions
- Interventions
- First Posted Date
- 2011-10-14
- Last Posted Date
- 2018-09-27
- Target Recruit Count
- 178
- Registration Number
- NCT01451827
- Locations
- 🇺🇸
Otsuka Investigational Site, Charlottesville, Virginia, United States
🇺🇸Otsuka Investigational Site 2, Aurora, Colorado, United States
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
- First Posted Date
- 2011-10-06
- Last Posted Date
- 2015-11-06
- Target Recruit Count
- 1036
- Registration Number
- NCT01447576
- Locations
- 🇺🇸
Artemis Institute for Clinical Research, San Diego, California, United States
🇺🇸Goldpoint Clinical Research, LLC, Indianapolis, Indiana, United States
🇺🇸Oregon Center for Clinical Investigations, Inc., Portland, Oregon, United States
Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
- Conditions
- Interventions
- First Posted Date
- 2011-09-21
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 232
- Registration Number
- NCT01438060
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
- Conditions
- Interventions
- First Posted Date
- 2011-09-13
- Last Posted Date
- 2015-05-07
- Target Recruit Count
- 493
- Registration Number
- NCT01432444
Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
- Conditions
- First Posted Date
- 2011-09-08
- Last Posted Date
- 2015-04-23
- Target Recruit Count
- 3409
- Registration Number
- NCT01430494
- Locations
- 🇺🇸
Otsuka Investigational Site 2, Peoria, Arizona, United States
🇫🇷Otuska Investigational Site, Lyon cedex 3, France
🇬🇧Otsuka Investigational Site, Wolverhampton, United Kingdom